Hepatitis C transmission and treatment as prevention – The role of the injecting network
Margaret Hellard(The Alfred Hospital), Garry Robins(The University of Melbourne), Peter Higgs(Curtin University), Rachel Sacks‐Davis(Burnet Institute), David A. Rolls(Australian Psychological Society), Campbell Aitken(Burnet Institute), Alexander Thompson(The University of Melbourne), Emma S. McBryde(The University of Queensland)
Cited by 65
Related Papers
Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees
|The Lancet|2016|648
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission
|The Lancet. Gastroenterology & hepatology|2019|539
Serum Hepatitis B Surface Antigen and Hepatitis B E Antigen Titers: Disease Phase Influences Correlation With Viral Load and Intrahepatic Hepatitis B Virus Markers
|Hepatology|2010|409
The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection
|Hepatology|2013|393
Hepatitis C Treatment for Injection Drug Users: A Review of the Available Evidence
|Clinical Infectious Diseases|2009|234